References Zheng Y, Ma AG, Zheng MC, Wang QZ, Liang H, Han XX, Schouten EG
When to Escalate Treatment: Combination Therapy Options If single-agent optimization fails after 812 weeks, PlexusDx's GLP-Squared combination therapy merges semaglutide and tirzepatide in one injection, targeting both GLP-1 and GIP pathways simultaneously
Working with providers like TrimBody M.D
Healthcare providers generally recommend FDA-approved medications because their safety and effectiveness have been thoroughly tested
Masking of folic acid deficiency: B12 supplementation may correct hematological abnormalities associated with folic acid deficiency while leaving neurological damage unaddressed
doi: 10.1038/s41420-024-01861-3 73 LiuYZhangWWangHLiuHYuQLuoXet al